Clinical Trial Update: Eze/Simva Switch Study in Diabetics (0653A-807) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating switching between ezetimibe and simvastatin in adults with Type 2 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Organon and Co | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED